Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
INVO Fertility ( (IVF) ) has provided an announcement.
On October 6, 2025, an institutional investor in INVO Fertility, Inc. exercised its Additional Investment Right to acquire 200 shares of Series C-2 Convertible Preferred Stock for $200,000. This transaction resulted in an adjusted conversion price of $0.6643 per share and was conducted as a private offering under the Securities Act exemptions, impacting the company’s financial structure and shareholder equity.
The most recent analyst rating on (IVF) stock is a Sell with a $1.50 price target. To see the full list of analyst forecasts on INVO Fertility stock, see the IVF Stock Forecast page.
Spark’s Take on IVF Stock
According to Spark, TipRanks’ AI Analyst, IVF is a Underperform.
The overall stock score is primarily impacted by poor financial performance and bearish technical indicators. The company’s significant operational losses and high leverage pose substantial risks. The negative P/E ratio and lack of dividend yield further weaken the valuation. Despite a positive corporate event, the overall outlook remains challenging.
To see Spark’s full report on IVF stock, click here.
More about INVO Fertility
Average Trading Volume: 1,528,572
Technical Sentiment Signal: Strong Sell
Current Market Cap: $3.61M
See more insights into IVF stock on TipRanks’ Stock Analysis page.